Skip to main navigation Skip to search Skip to main content

Usefulness of neutrophil-to-lymphocyte ratio as a predictor of functional outcome in patients with acute ischemic stroke after thrombolysis therapy

  • Sadaf Majid
  • , Omair Ul Haq Lodhi
  • , Asfandyar Khan Niazi
  • , Somair Ul Haq Lodhi
  • , Maimoona Siddiqui

Research output: Contribution to journal › Article › peer-review

Abstract

In stroke patients, a high neutrophil-to-lymphocyte ratio (NLR) has been associated with poor functional outcome at 3 months, higher mortality, and a higher hemorrhagic transformation. We assessed the role of NLR in patients with acute ischemic stroke who received thrombolysis. The charts of 98 patients treated between 2015 and 2019 were retrospectively reviewed. The mean NLR was compared using an independent Student’s t test. At 3 months, a good functional outcome was seen in 31 patients (32%) and a poor functional outcome was seen in 67 patients (68%). Patients with NLR >2.39 had a poor functional outcome (odds ratio 2.7; 95% confidence interval 1.11–6.39; P < 0.02). Our study revealed that patients who present with acute ischemic stroke and have an increased NLR at the time of administration of thrombolysis have a poor functional outcome at 3 months.

Original languageEnglish (US)
Pages (from-to)664-667
Number of pages4
JournalBaylor University Medical Center Proceedings
Volume34
Issue number6
DOIs
StatePublished - 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
© Copyright © 2021 Baylor University Medical Center.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Acute ischemic stroke
  • developing country
  • functional outcome
  • neutrophil-to-lymphocyte ratio
  • thrombolysis

Fingerprint

Dive into the research topics of 'Usefulness of neutrophil-to-lymphocyte ratio as a predictor of functional outcome in patients with acute ischemic stroke after thrombolysis therapy'. Together they form a unique fingerprint.

Cite this